Zonisamide, Serum or Plasma
Also known as: Zonegran®
Use
Monitor drug levels for optimal therapy
Special Instructions
Not provided.
Limitations
This test may be affected by drug half-life alterations when co-administered with P450 inducers like phenytoin and carbamazepine, leading to reduced zonisamide half-life. Results may not be accurate for patients with conditions or medications affecting metabolic pathways involving CYP3A4 and CYP2D6 enzymes.
Methodology
Immunoassay
Biomarkers
Zonisamide
Analyte
LOINC Codes
- 29620-2 - Zonisamide SerPl-mCnc
- 29620-2 - Zonisamide SerPl-mCnc
Result Turnaround Time
2-4 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
0.5 mL
Minimum Volume
0.3 mL
Container
Red-top tube, sodium heparin tube, potassium EDTA tube or lithium heparin tube
Collection Instructions
Separate serum from cells within 45 minutes of collection and transfer to a plastic transport tube.
Patient Preparation
Collect samples immediately prior to next dose.
Storage Instructions
Room temperature
Causes for Rejection
Hemolyzed samples; gel separator tubes; clotted specimen; samples not separated from blood cells
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 7 days |
| Frozen | 4 weeks |
Other tests from different labs that may be relevant